A novel function of caspase‐8 in the regulation of androgen‐receptor‐driven gene expression

[1]  G. Wang,et al.  Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells , 2006, Oncogene.

[2]  Wei Xu.  Nuclear receptor coactivators: the key to unlock chromatin. , 2005, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[3]  W. Gerald,et al.  The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. , 2005, Molecular endocrinology.

[4]  Chawnshang Chang,et al.  Androgen receptor corepressors: An overview , 2005, The Prostate.

[5]  L. Salmena,et al.  Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor , 2005, Science.

[6]  Bin He,et al.  Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction , 2005, Molecular and Cellular Biology.

[7]  A. Baniahmad.  Nuclear hormone receptor co-repressors , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  Hong-Chiang Chang,et al.  Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. , 2005, Molecular endocrinology.

[9]  Colleen Nelson,et al.  Mechanisms of the development of androgen independence in prostate cancer , 2005, World Journal of Urology.

[10]  D. Tindall,et al.  Regulation of androgen receptor signaling in prostate cancer , 2005, Expert review of anticancer therapy.

[11]  Bin He,et al.  Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance. , 2004, Molecular cell.

[12]  T. Kang,et al.  Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.

[13]  Zhengxin Wang,et al.  Modulation of androgen receptor‐dependent transcription by resveratrol and genistein in prostate cancer cells , 2004, The Prostate.

[14]  G. Salvesen,et al.  Mechanisms of caspase activation. , 2003, Current opinion in cell biology.

[15]  E. Rosen,et al.  Acetylation of Androgen Receptor Enhances Coactivator Binding and Promotes Prostate Cancer Cell Growth , 2003, Molecular and Cellular Biology.

[16]  I. Condò,et al.  A caspaselike activity is triggered by LPS and is required for survival of human dendritic cells. , 2003, Blood.

[17]  Chawnshang Chang,et al.  Expression and Degradation of Androgen Receptor: Mechanism and Clinical Implication , 2003 .

[18]  K. McCall,et al.  Stage-specific regulation of caspase activity in drosophila oogenesis. , 2003, Developmental biology.

[19]  Zhengxin Wang,et al.  Identification of a Highly Conserved Domain in the Androgen Receptor That Suppresses the DNA-binding Domain-DNA Interactions* , 2003, The Journal of Biological Chemistry.

[20]  Chawnshang Chang,et al.  Molecular communication between androgen receptor and general transcription machinery , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[21]  David Baltimore,et al.  CARD11 mediates factor‐specific activation of NF‐κB by the T cell receptor complex , 2002, The EMBO journal.

[22]  E. Gelmann,et al.  Molecular biology of the androgen receptor. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  E. Wilson,et al.  The NH(2)-terminal and carboxyl-terminal interaction in the human androgen receptor. , 2002, Molecular genetics and metabolism.

[24]  C. Heinlein,et al.  Androgen receptor (AR) coregulators: an overview. , 2002, Endocrine reviews.

[25]  B. Haendler,et al.  Androgen-selective gene regulation in the prostate. , 2002, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  Yigong Shi,et al.  Mechanisms of caspase activation and inhibition during apoptosis. , 2002, Molecular cell.

[27]  J. Maher,et al.  Anti-Fas Induces Hepatic Chemokines and Promotes Inflammation by an NF-κB-independent, Caspase-3-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[28]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[29]  J. L. Shenk,et al.  p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction* , 2001, The Journal of Biological Chemistry.

[30]  R. Roeder,et al.  Inhibition of Androgen Receptor-Mediated Transcription by Amino-Terminal Enhancer of split , 2001, Molecular and Cellular Biology.

[31]  L. Hood,et al.  Activation of the NF-κB pathway by Caspase 8 and its homologs , 2000, Oncogene.

[32]  O. Jänne,et al.  The RING finger protein SNURF modulates nuclear trafficking of the androgen receptor. , 2000, Journal of cell science.

[33]  O. Jänne,et al.  Androgen-receptor-interacting nuclear proteins. , 2000, Biochemical Society transactions.

[34]  J. A. Kemppainen,et al.  FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen Receptor* , 2000, The Journal of Biological Chemistry.

[35]  G. Salvesen.  Caspase 8: igniting the death machine. , 1999, Structure.

[36]  S. Srinivasula,et al.  Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1 , 1999, Nature.

[37]  R. Cardiff,et al.  Roles for Nkx3.1 in prostate development and cancer. , 1999, Genes & development.

[38]  J. Trapman,et al.  Mechanisms of androgen receptor activation and function , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[39]  Noah Craft,et al.  A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.

[40]  J. Trapman,et al.  Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). , 1998, Molecular endocrinology.

[41]  D. Tindall,et al.  Isolation and androgen regulation of the human homeobox cDNA, NKX3.1 , 1998, The Prostate.

[42]  H. Steller,et al.  Requirement for DCP-1 caspase during Drosophila oogenesis. , 1998, Science.

[43]  J. A. Kemppainen,et al.  Intermolecular NH2-/Carboxyl-terminal Interactions in Androgen Receptor Dimerization Revealed by Mutations That Cause Androgen Insensitivity* , 1998, The Journal of Biological Chemistry.

[44]  T. Ikonen,et al.  Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators* , 1997, The Journal of Biological Chemistry.

[45]  M. Gleave,et al.  Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP* , 1997, The Journal of Biological Chemistry.

[46]  R. Sager,et al.  Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Trapman,et al.  An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. , 1997, Molecular endocrinology.

[48]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[49]  J. D. Miller,et al.  Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (*) , 1996, The Journal of Biological Chemistry.

[50]  E. Langley,et al.  Evidence for an Anti-parallel Orientation of the Ligand-activated Human Androgen Receptor Dimer (*) , 1995, The Journal of Biological Chemistry.

[51]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[52]  F. S. French,et al.  Androgen receptor defects: historical, clinical, and molecular perspectives. , 1995, Endocrine reviews.

[53]  M. Shago,et al.  Inhibition of nuclear hormone receptor activity by calreticulin , 1994, Nature.

[54]  L. Salmena,et al.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor. , 2005, Science.

[55]  E. Wilson,et al.  Methods for detecting domain interactions in nuclear receptors. , 2003, Methods in enzymology.

[56]  Chawnshang Chang,et al.  Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication. , 2003, The Journal of clinical endocrinology and metabolism.

[57]  H. Shu,et al.  Activation of NF-kappaB by FADD, Casper, and caspase-8. , 2000, The Journal of biological chemistry.

[58]  L. Hood,et al.  Activation of the NF-kappaB pathway by caspase 8 and its homologs. , 2000, Oncogene.

[59]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.